$BDX News

UBS Initiates Coverage of Becton, Dickinson and (BDX) with Buy Recommendation

BD (BDX) Stock May Be 19% Undervalued On Fresh MedTech AI Adoption News

Becton Dickinson (BDX) On Its Brazil Semaglutide Push And The Valuation Narrative

EMS and BD expand access to GLP-1 therapies in Brazil with semaglutide launch

BD Board Declares Dividend

UBS Initiates Coverage On Becton Dickinson with Buy Rating, Announces Price Target of $190

Mike Garrison to Retire from BD

Becton, Dickinson and Company Earnings Preview: What to Expect

BD to Announce Financial Results for its Third Quarter of Fiscal 2026

Becton Dickinson (BDX) Stock Trades At A Discount On Cash Flow And Earnings

Becton Dickinson (BDX) Joins New Russell Indexes, Is The Stock Below Fair Value?

Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report?

Evercore ISI Group Maintains Outperform on Becton Dickinson, Lowers Price Target to $180

Becton, Dickinson and Company: Now Is A Great Time To Buy

Becton, Dickinson - Stable Undervaluation In 1Q26, Upside Is There

BD (BDX) Receives Vizient Innovative Technology Contract for CentroVena One Insertion System

BD Awarded Vizient Innovative Technology Contract for CentroVena One™ Insertion System

Becton Dickinson (BDX) Issues Voluntary Recall for Select Skin Preparation Products

Becton Dickinson's CentroVena One Insertion System Awarded Innovative Technology Contract From Vizient; Terms Not Disclosed

Here's Why You Should Retain BDX Stock in Your Portfolio Now